BioCentury
ARTICLE | Company News

Advanomics, Sunshine Biopharma deal

November 9, 2015 8:00 AM UTC

Sunshine purchased U.S. Patent No. 8,236,935 from Advanomics, which owns about 23% of Sunshine. The patent covers all rights related to Sunshine’s Adva-27a in the U.S. Sunshine is planning a Phase I ...